New imaging study maps Drug's path in advanced cancers
NCT ID NCT05638334
First seen Feb 18, 2026 · Last updated May 16, 2026 · Updated 13 times
Summary
This study aimed to see how a new drug (S095012) spreads through the body and targets tumors in people with advanced solid cancers. Only 3 people took part before the study was stopped early. The main goal was to use PET scans to track the drug, not to treat the cancer.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
UMC Gronningen Oncologie
Groningen, 9713 AZ, Netherlands
Conditions
Explore the condition pages connected to this study.